The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of metallic stents and it is still poorly investigated. Intravascular imaging techniques are useful tools for corroborating or excluding possible mechanisms of intra-scaffold restenosis. In these novel devices intravascular imaging should be systematically used for a better comprehension of the in-scaffold restenosis mechanism
markdownabstract__Abstract__ The pattern of vascular responses following stent/scaffold implantat...
Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient vessel suppor...
Current generation of drug-eluting stents has significantly improved the outcomes of percutaneous co...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
In the field of interventional cardiology, the era of vascular reparative therapy has started with t...
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is sti...
In recent years, bioresorbable vascular scaffolds (BVS) have been introduced into clinical practice....
Treatment of in-stent restenosis (ISR) is still challenging. In this setting, the use of bioresorbab...
Coronary in-stent restenosis (ISR) is a clinical problem for which a satisfactory solution has not b...
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) pr...
Bioresorbable vascular scaffolds (BRS) represent a novel approach for coronary revascularization off...
Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel suppor...
textabstractBackground - As bioresorbable vascular scaffolds (BVSs) are being increasingly used in c...
Background: Bioresorption of bioresorbable vascular scaffold (BVS) may lead to late coronary lumen e...
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application ...
markdownabstract__Abstract__ The pattern of vascular responses following stent/scaffold implantat...
Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient vessel suppor...
Current generation of drug-eluting stents has significantly improved the outcomes of percutaneous co...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
In the field of interventional cardiology, the era of vascular reparative therapy has started with t...
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is sti...
In recent years, bioresorbable vascular scaffolds (BVS) have been introduced into clinical practice....
Treatment of in-stent restenosis (ISR) is still challenging. In this setting, the use of bioresorbab...
Coronary in-stent restenosis (ISR) is a clinical problem for which a satisfactory solution has not b...
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) pr...
Bioresorbable vascular scaffolds (BRS) represent a novel approach for coronary revascularization off...
Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel suppor...
textabstractBackground - As bioresorbable vascular scaffolds (BVSs) are being increasingly used in c...
Background: Bioresorption of bioresorbable vascular scaffold (BVS) may lead to late coronary lumen e...
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application ...
markdownabstract__Abstract__ The pattern of vascular responses following stent/scaffold implantat...
Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient vessel suppor...
Current generation of drug-eluting stents has significantly improved the outcomes of percutaneous co...